Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niels Pallisgaard

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 30, 2018
Total cell-free DNA, carcinoembryonic antigen, and C-reactive protein for assessment of prognosis in patients with metastatic colorectal cancerKaren-Lise Garm Spindler, Christina Demuth, Boe Sandahl Sorensen, et al.
Molecular Oncology|April 25, 2018
Correlation between circulating cell-free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA-mutated metastatic breast cancerAnnette R Kodahl, Sidse Ehmsen, Niels Pallisgaard, et al.
Journal of Cancer Research and Clinical Oncology|March 13, 2013
Plasma HER2 amplification in cell-free DNA during neoadjuvant chemotherapy in breast cancerTroels Bechmann, Rikke Fredslund Andersen, Niels Pallisgaard, et al.
European Journal of Haematology|April 16, 2019
Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assayLasse Kjaer, Vibe Skov, Morten T Andersen, et al.
Leukemia & Lymphoma|August 10, 2017
Sorted peripheral blood cells identify CALR mutations in B- and T-lymphocytesLasse Kjaer, Morten O Holmström, Sabrina Cordua, et al.
Plos One|October 21, 2016
Differential Dynamics of CALR Mutant Allele Burden in Myeloproliferative Neoplasms during Interferon Alfa TreatmentLasse Kjær, Sabrina Cordua, Morten O Holmström, et al.
Clinical Epidemiology|November 9, 2016
The Danish National Chronic Myeloid Neoplasia RegistryMarie Bak, Else Helene Ibfelt, Thomas Stauffer Larsen, et al.
Clinical Colorectal Cancer|January 1, 2025
Exploring Early Kinetic Profiles of CEA, ctDNA and cfDNA in Patients With RAS-/BRAF-Mutated Metastatic Colorectal CancerJulian Hamfjord, Tormod Kyrre Guren, Bengt Glimelius, et al.
Journal of Theoretical Biology|January 8, 2019
Bridging blood cancers and inflammation: The reduced Cancitis modelJohnny T Ottesen, Rasmus K Pedersen, Zamra Sajid, et al.
International Journal of Cancer|May 7, 2021
Clinicopathological factors associated with tumour-specific mutation detection in plasma of patients with RAS-mutated or BRAF-mutated metastatic colorectal cancerJulian Hamfjord, Tormod Kyrre Guren, Bengt Glimelius, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 30, 2018
Total cell-free DNA, carcinoembryonic antigen, and C-reactive protein for assessment of prognosis in patients with metastatic colorectal cancerKaren-Lise Garm Spindler, Christina Demuth, Boe Sandahl Sorensen, et al.
Molecular Oncology|April 25, 2018
Correlation between circulating cell-free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA-mutated metastatic breast cancerAnnette R Kodahl, Sidse Ehmsen, Niels Pallisgaard, et al.
Journal of Cancer Research and Clinical Oncology|March 13, 2013
Plasma HER2 amplification in cell-free DNA during neoadjuvant chemotherapy in breast cancerTroels Bechmann, Rikke Fredslund Andersen, Niels Pallisgaard, et al.
European Journal of Haematology|April 16, 2019
Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assayLasse Kjaer, Vibe Skov, Morten T Andersen, et al.
Leukemia & Lymphoma|August 10, 2017
Sorted peripheral blood cells identify CALR mutations in B- and T-lymphocytesLasse Kjaer, Morten O Holmström, Sabrina Cordua, et al.
Plos One|October 21, 2016
Differential Dynamics of CALR Mutant Allele Burden in Myeloproliferative Neoplasms during Interferon Alfa TreatmentLasse Kjær, Sabrina Cordua, Morten O Holmström, et al.
Clinical Epidemiology|November 9, 2016
The Danish National Chronic Myeloid Neoplasia RegistryMarie Bak, Else Helene Ibfelt, Thomas Stauffer Larsen, et al.
Clinical Colorectal Cancer|January 1, 2025
Exploring Early Kinetic Profiles of CEA, ctDNA and cfDNA in Patients With RAS-/BRAF-Mutated Metastatic Colorectal CancerJulian Hamfjord, Tormod Kyrre Guren, Bengt Glimelius, et al.
Journal of Theoretical Biology|January 8, 2019
Bridging blood cancers and inflammation: The reduced Cancitis modelJohnny T Ottesen, Rasmus K Pedersen, Zamra Sajid, et al.
International Journal of Cancer|May 7, 2021
Clinicopathological factors associated with tumour-specific mutation detection in plasma of patients with RAS-mutated or BRAF-mutated metastatic colorectal cancerJulian Hamfjord, Tormod Kyrre Guren, Bengt Glimelius, et al.
Pageof 7